Amneal Pharmaceuticals, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.6 Billion | 4/18 | ITCI $13.6B |
NBIX $11.5B |
ALKS $5.8B |
AMRX $3.6B |
DCPH $2.2B |
DVAX $1.7B |
AMPH $1.5B |
ANIP $1.2B |
PAHC $1.0B |
COLL $956.5M |
EOLS $933.4M |
IRWD $307.3M |
PROC $114.0M |
ASRT $80.2M |
SSIC $66.7M |
EGRX $15.2M |
ACRX $14.6M |
AGRX $10.4M |
Gross Margin | 38% | 17/18 | IRWD 100% |
ANIP 100% |
ACRX 100% |
SSIC 100% |
NBIX 99% |
DCPH 92% |
ITCI 91% |
DVAX 84% |
ALKS 83% |
EGRX 74% |
ASRT 74% |
AGRX 73% |
EOLS 70% |
COLL 61% |
PROC 58% |
AMPH 54% |
AMRX 38% |
PAHC 32% |
Profit Margin | 2% | 11/18 | SSIC 67% |
IRWD 34% |
ALKS 24% |
DVAX 22% |
NBIX 21% |
AMPH 21% |
EGRX 8% |
PROC 7% |
COLL 6% |
PAHC 3% |
AMRX 2% |
ASRT -10% |
ITCI -15% |
ANIP -16% |
EOLS -32% |
ACRX -100% |
AGRX -100% |
DCPH -100% |
EBITDA margin | 13% | 10/18 | SSIC 147534% |
NBIX 31% |
AMPH 30% |
IRWD 28% |
ALKS 28% |
COLL 22% |
ANIP 20% |
EGRX 17% |
PROC 14% |
AMRX 13% |
DVAX 13% |
PAHC 10% |
ASRT -10% |
ITCI -22% |
EOLS -38% |
AGRX -49% |
DCPH -105% |
ACRX -1210% |
Quarterly Revenue | $702.5 Million | 1/18 | AMRX $702.5M |
NBIX $622.1M |
ALKS $378.1M |
PAHC $260.4M |
AMPH $188.8M |
ITCI $175.2M |
COLL $159.3M |
ANIP $148.3M |
PROC $118.4M |
IRWD $91.6M |
DVAX $79.3M |
EGRX $64.6M |
EOLS $60.2M |
DCPH $45.0M |
ASRT $29.2M |
AGRX $5.6M |
SSIC $1.9M |
ACRX $117,000 |
Quarterly Earnings | $11.8 Million | 6/18 | NBIX $129.8M |
ALKS $92.4M |
AMPH $40.4M |
IRWD $31.1M |
DVAX $17.6M |
AMRX $11.8M |
COLL $9.3M |
PROC $8.2M |
PAHC $7.0M |
EGRX $5.2M |
SSIC $1.3M |
ACRX -$1.4M |
ASRT -$2.8M |
AGRX -$11.9M |
EOLS -$19.2M |
ANIP -$24.2M |
ITCI -$26.3M |
DCPH -$45.1M |
Quarterly Free Cash Flow | $0 Million | 9/18 | NBIX $149.9M |
ALKS $97.0M |
AMPH $46.2M |
PROC $39.7M |
ANIP $21.5M |
DVAX $18.1M |
PAHC $3.0M |
SSIC $840,198 |
AMRX -$0 |
IRWD -$0 |
AGRX -$0 |
ASRT -$35,000 |
EGRX -$132,000 |
ACRX -$3.0M |
EOLS -$4.7M |
COLL -$9.2M |
ITCI -$27.2M |
DCPH -$54.7M |
Trailing 4 Quarters Revenue | $2.7 Billion | 1/18 | AMRX $2.7B |
NBIX $2.2B |
ALKS $1.5B |
PAHC $1.0B |
AMPH $698.7M |
ITCI $612.9M |
COLL $599.2M |
ANIP $555.5M |
PROC $414.1M |
IRWD $378.4M |
DVAX $259.5M |
EGRX $257.6M |
EOLS $245.7M |
DCPH $174.9M |
ASRT $125.8M |
AGRX $21.6M |
SSIC $7.8M |
ACRX $369,000 |
Trailing 4 Quarters Earnings | -$161.7 Million | 17/18 | AMRX $702.5M |
NBIX $622.1M |
ALKS $378.1M |
PAHC $260.4M |
AMPH $188.8M |
ITCI $175.2M |
COLL $159.3M |
ANIP $148.3M |
PROC $118.4M |
IRWD $91.6M |
DVAX $79.3M |
EGRX $64.6M |
EOLS $60.2M |
DCPH $45.0M |
ASRT $29.2M |
AGRX $5.6M |
SSIC $1.9M |
ACRX $117,000 |
Quarterly Earnings Growth | 21% | 10/18 | PAHC 187% |
EGRX 155% |
SSIC 128% |
IRWD 103% |
ASRT 99% |
ALKS 93% |
ACRX 80% |
NBIX 56% |
DVAX 23% |
AMRX 21% |
DCPH 2% |
ITCI -9% |
EOLS -13% |
AMPH -18% |
COLL -55% |
PROC -64% |
AGRX -212% |
ANIP -343% |
Annual Earnings Growth | -456% | 18/18 | PROC 2764% |
SSIC 352% |
IRWD 103% |
ASRT 73% |
COLL 49% |
ITCI 43% |
AMPH 24% |
EOLS 22% |
NBIX 4% |
DVAX 0% |
DCPH -4% |
AGRX -8% |
PAHC -34% |
ALKS -50% |
EGRX -87% |
ACRX -104% |
ANIP -125% |
AMRX -456% |
Quarterly Revenue Growth | 13% | 8/18 | SSIC 77% |
ITCI 39% |
DCPH 35% |
NBIX 25% |
EOLS 22% |
COLL 17% |
DVAX 14% |
AMRX 13% |
ANIP 13% |
PAHC 13% |
PROC 7% |
AMPH 5% |
AGRX 1% |
ALKS -1% |
EGRX -13% |
ASRT -18% |
IRWD -19% |
ACRX -77% |
Annual Revenue Growth | 11% | 9/18 | SSIC 134% |
ITCI 34% |
AGRX 27% |
EOLS 25% |
DCPH 23% |
NBIX 21% |
ANIP 15% |
AMPH 13% |
AMRX 11% |
COLL 10% |
PAHC 5% |
DVAX 4% |
PROC -7% |
IRWD -13% |
ASRT -21% |
ALKS -33% |
EGRX -39% |
ACRX -83% |
Cash On Hand | $74.0 Million | 10/18 | ITCI $464.3M |
ALKS $396.3M |
NBIX $349.1M |
AMPH $192.1M |
ANIP $145.0M |
DVAX $119.3M |
DCPH $91.2M |
IRWD $88.2M |
EOLS $85.0M |
AMRX $74.0M |
PAHC $51.8M |
COLL $39.0M |
ASRT $38.0M |
SSIC $29.8M |
PROC $17.6M |
EGRX $15.4M |
ACRX $13.4M |
AGRX $2.8M |
Short Term Debt | $241.0 Million | 1/18 | AMRX $241.0M |
PROC $69.2M |
COLL $65.9M |
NBIX $34.8M |
ALKS $9.2M |
EGRX $8.3M |
ANIP $7.2M |
AMPH $4.5M |
ITCI $4.2M |
DCPH $3.6M |
IRWD $3.2M |
EOLS $1.6M |
AGRX $289,000 |
DVAX -$0 |
PAHC -$0 |
ACRX -$0 |
ASRT -$0 |
SSIC -$0 |
Long Term Debt | $2.3 Billion | 1/18 | AMRX $2.3B |
COLL $808.5M |
AMPH $625.4M |
ANIP $618.2M |
ALKS $356.9M |
PAHC $287.7M |
NBIX $251.4M |
DVAX $250.2M |
PROC $220.7M |
IRWD $211.7M |
EGRX $61.9M |
ASRT $38.8M |
DCPH $21.4M |
ITCI $13.5M |
EOLS $7.1M |
ACRX $0 |
AGRX $0 |
SSIC $0 |
PE | -1.00 | 11/18 | DVAX 68.72 |
PAHC 59.97 |
NBIX 29.72 |
ALKS 15.31 |
SSIC 12.36 |
COLL 10.80 |
AMPH 9.46 |
IRWD 3.47 |
PROC 2.18 |
EGRX 0.97 |
AMRX -1.00 |
ITCI -1.00 |
ANIP -1.00 |
ACRX -1.00 |
AGRX -1.00 |
DCPH -1.00 |
EOLS -1.00 |
ASRT -1.00 |
PS | 1.33 | 12/18 | ACRX 39.51 |
ITCI 22.16 |
DCPH 12.65 |
SSIC 8.60 |
DVAX 6.49 |
NBIX 5.11 |
ALKS 3.88 |
EOLS 3.80 |
ANIP 2.23 |
AMPH 2.13 |
COLL 1.60 |
AMRX 1.33 |
PAHC 1.00 |
IRWD 0.81 |
ASRT 0.64 |
AGRX 0.48 |
PROC 0.28 |
EGRX 0.06 |
PB | 0.00 | 17/18 | EOLS 158.47 |
ITCI 11.86 |
DCPH 7.00 |
ALKS 4.52 |
NBIX 4.22 |
COLL 4.08 |
PAHC 4.04 |
PROC 2.96 |
ANIP 2.87 |
DVAX 2.47 |
IRWD 2.39 |
AMPH 2.05 |
ACRX 0.80 |
SSIC 0.75 |
ASRT 0.61 |
EGRX 0.06 |
AMRX 0.00 |
AGRX 0.00 |
PC | 48.25 | 1/18 | AMRX 48.25 |
NBIX 32.85 |
ITCI 29.25 |
COLL 24.55 |
DCPH 24.26 |
PAHC 20.14 |
ALKS 14.73 |
DVAX 14.12 |
EOLS 10.98 |
ANIP 8.54 |
AMPH 7.76 |
PROC 6.49 |
AGRX 3.66 |
IRWD 3.48 |
SSIC 2.24 |
ASRT 2.11 |
ACRX 1.09 |
EGRX 0.99 |
Liabilities to Equity | 0.00 | 16/18 | EOLS 37.98 |
PROC 11.68 |
COLL 5.98 |
PAHC 2.74 |
ANIP 2.11 |
IRWD 2.03 |
AMPH 1.12 |
ASRT 1.11 |
ALKS 0.67 |
EGRX 0.61 |
DVAX 0.56 |
DCPH 0.33 |
NBIX 0.30 |
ACRX 0.27 |
ITCI 0.16 |
AMRX 0.00 |
AGRX 0.00 |
SSIC 0.00 |
ROA | -0.05 | 12/18 | IRWD 23% | ALKS 18% | NBIX 11% | AMPH 10% | PROC 10% | SSIC 6% | COLL 5% | EGRX 4% | DVAX 2% | PAHC 2% | ANIP -1% | AMRX -5% | ITCI -7% | EOLS -24% | ASRT -25% | ACRX -34% | DCPH -45% | AGRX -106% |
ROE | 1.73 | 1/18 | AMRX 173% |
PROC 133% |
AGRX 72% |
IRWD 69% |
COLL 38% |
ALKS 29% |
AMPH 22% |
NBIX 14% |
PAHC 7% |
EGRX 6% |
SSIC 6% |
DVAX 4% |
ANIP -2% |
ITCI -8% |
ACRX -43% |
ASRT -52% |
DCPH -60% |
EOLS -942% |
Current Ratio | 0.97 | 16/18 | ITCI 7.37 |
ACRX 4.70 |
NBIX 4.33 |
DCPH 4.01 |
DVAX 2.79 |
EGRX 2.65 |
ALKS 2.50 |
ASRT 1.90 |
AMPH 1.89 |
ANIP 1.50 |
IRWD 1.49 |
PAHC 1.37 |
COLL 1.17 |
PROC 1.08 |
EOLS 1.03 |
AMRX 0.97 |
AGRX 0.41 |
SSIC -1.00 |
Quick Ratio | 0.02 | 17/18 | DVAX 68.72 |
PAHC 59.97 |
NBIX 29.72 |
ALKS 15.31 |
SSIC 12.36 |
COLL 10.80 |
AMPH 9.46 |
IRWD 3.47 |
PROC 2.18 |
EGRX 0.97 |
AMRX -1.00 |
ITCI -1.00 |
ANIP -1.00 |
ACRX -1.00 |
AGRX -1.00 |
DCPH -1.00 |
EOLS -1.00 |
ASRT -1.00 |
Long Term Debt to Equity | -24.19 | 18/18 | PROC} 5.60 |
COLL} 3.45 |
IRWD} 1.65 |
ANIP} 1.52 |
EOLS} 1.20 |
PAHC} 1.11 |
AMPH} 0.86 |
DVAX} 0.37 |
ASRT} 0.30 |
ALKS} 0.28 |
EGRX} 0.25 |
NBIX} 0.09 |
DCPH} 0.07 |
ITCI} 0.01 |
ACRX} 0.00 |
AGRX} 0.00 |
SSIC} 0.00 |
AMRX} -24.19 |
Debt to Equity | -26.77 | 18/18 | PROC 7.36 |
COLL 3.73 |
IRWD 1.67 |
ANIP 1.54 |
EOLS 1.47 |
PAHC 1.11 |
AMPH 0.87 |
DVAX 0.37 |
ASRT 0.30 |
EGRX 0.28 |
ALKS 0.28 |
NBIX 0.09 |
DCPH 0.08 |
ITCI 0.02 |
ACRX 0.00 |
SSIC 0.00 |
AGRX -0.01 |
AMRX -26.77 |
Burn Rate | 0.53 | 10/18 | ITCI 16.63 |
PAHC 11.44 |
ACRX 9.87 |
ASRT 8.66 |
EOLS 4.28 |
ANIP 2.86 |
DCPH 1.95 |
COLL 0.99 |
PROC 0.98 |
AMRX 0.53 |
AGRX 0.24 |
NBIX -3.14 |
IRWD -4.04 |
ALKS -5.23 |
AMPH -13.44 |
DVAX -15.73 |
SSIC -23.41 |
EGRX -25.01 |
Cash to Cap | 0.02 | 18/18 | EGRX 1.01 |
ACRX 0.92 |
ASRT 0.47 |
SSIC 0.45 |
IRWD 0.29 |
AGRX 0.27 |
PROC 0.15 |
AMPH 0.13 |
ANIP 0.12 |
EOLS 0.09 |
DVAX 0.07 |
ALKS 0.07 |
PAHC 0.05 |
COLL 0.04 |
DCPH 0.04 |
NBIX 0.03 |
ITCI 0.03 |
AMRX 0.02 |
CCR | 0.00 | 13/18 | PROC 4.85 |
ACRX 2.18 |
DCPH 1.21 |
NBIX 1.15 |
AMPH 1.14 |
ALKS 1.05 |
DVAX 1.03 |
ITCI 1.03 |
SSIC 0.66 |
PAHC 0.44 |
EOLS 0.25 |
ASRT 0.01 |
AMRX 0.00 |
IRWD 0.00 |
AGRX 0.00 |
EGRX -0.03 |
ANIP -0.89 |
COLL -0.99 |
EV to EBITDA | 67.58 | 2/18 | DVAX} 180.13 |
AMRX} 67.58 |
NBIX} 59.44 |
ANIP} 58.77 |
ALKS} 55.42 |
COLL} 51.44 |
PAHC} 47.75 |
AMPH} 33.82 |
PROC} 23.63 |
IRWD} 16.93 |
EGRX} 6.51 |
SSIC} 0.01 |
ACRX} -0.84 |
AGRX} -2.86 |
ASRT} -26.59 |
EOLS} -37.73 |
DCPH} -45.43 |
ITCI} -339.27 |
EV to Revenue | 2.24 | 12/18 | ITCI 21.43 |
DCPH 12.27 |
DVAX 7.00 |
NBIX 5.07 |
SSIC 4.76 |
ALKS 3.86 |
EOLS 3.49 |
ACRX 3.22 |
ANIP 3.09 |
COLL 2.99 |
AMPH 2.76 |
AMRX 2.24 |
PAHC 1.22 |
IRWD 1.15 |
PROC 0.93 |
ASRT 0.64 |
AGRX 0.36 |
EGRX 0.27 |